These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30458453)

  • 1. Barriers to Using a Nationwide Skin Cancer Screening Program: Findings from Germany.
    Görig T; Schneider S; Schilling L; Diehl K
    Oncol Res Treat; 2018; 41(12):774-779. PubMed ID: 30458453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The many unanswered questions related to the German skin cancer screening programme.
    Stang A; Garbe C; Autier P; Jöckel KH
    Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to cervical cancer screening faced by immigrant women in Canada: a systematic scoping review.
    Ferdous M; Lee S; Goopy S; Yang H; Rumana N; Abedin T; Turin TC
    BMC Womens Health; 2018 Oct; 18(1):165. PubMed ID: 30305056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of a population-based skin cancer screening program: evidence from Germany.
    Kaiser M; Schiller J; Schreckenberger C
    Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
    Eisemann N; Waldmann A; Garbe C; Katalinic A
    Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the quality of skin cancer screening in Germany related to the specialization of the physician who performs it?: Results of a nationwide survey among participants of skin cancer screening.
    Görig T; Schneider S; Breitbart EW; Diehl K
    Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):454-460. PubMed ID: 33738871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic differences in the participation in "early detection of cancer examinations" in Germany--a review].
    Scheffer S; Dauven S; Sieverding M
    Gesundheitswesen; 2006 Mar; 68(3):139-46. PubMed ID: 16575692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
    Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with organized and opportunistic cancer screening: Results of the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2011.
    Kang M; Yoo KB; Park EC; Kwon K; Kim G; Kim DR; Kwon JA
    Asian Pac J Cancer Prev; 2014; 15(7):3279-86. PubMed ID: 24815483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities to inform German residents about the possibility of skin cancer screening and to inform stakeholders to take appropriate actions: A qualitative approach.
    Steeb T; Wessely A; Heppt MV; Erdmann M; Klug SJ; Berking C
    Cancer Med; 2023 May; 12(9):10829-10839. PubMed ID: 37062065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional differences in the health care of basal cell carcinoma].
    Augustin J; Schäfer I; Thiess P; Reusch M; Augustin M
    Hautarzt; 2016 Oct; 67(10):822-828. PubMed ID: 27465368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
    Schmitt J; Seidler A; Heinisch G; Sebastian G
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine skin cancer screening in Germany: First data on the impact on health care in dermatology.
    Augustin M; Blome C; Rustenbach SJ; Reusch M; Radtke M
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):674-80. PubMed ID: 20529170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary prevention in the context of skin cancer screening].
    Krensel M; Schäfer I; Zander N; Augustin M
    Hautarzt; 2019 Jun; 70(6):432-437. PubMed ID: 30707245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Salt Preference and Gastric Cancer Screening: An Analysis of a Nationwide Survey in Korea.
    Shin JY; Kim J; Choi KS; Suh M; Park B; Jun JK
    Cancer Res Treat; 2016 Jul; 48(3):1037-44. PubMed ID: 26693914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening participation: a systematic review.
    Wools A; Dapper EA; de Leeuw JR
    Eur J Public Health; 2016 Feb; 26(1):158-68. PubMed ID: 26370437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.